Detection of Extended-Spectrum β-lactamase-producing Enterobacteriaceae in a Healthcare Center from Maracaibo city, Venezuela
Armindo Perozo Mena,
Marín Milagros,
Maribel Castellano,
Eliana Ling Toledo,
Daniela Núñez,
Messaria Ginestre,
Jessica Villasmil,
José Bermúdez-González,
Rafael Villalobos,
Liliana Gómez-Gamboa
Affiliations
Armindo Perozo Mena
Escuela de Bioanálisis. Facultad de Medicina. La Universidad del Zulia. Centro de Referencia
Bacteriológica. Servicio autónomo Hospital Universitario de Maracaibo. Venezuela.
Marín Milagros
Maestría de Diagnóstico Bacteriológico. División de Estudios para Graduados. Facultad de Medicina, La Universidad del Zulia. Maracaibo, Venezuela
Maribel Castellano
Escuela de Bioanálisis. Facultad de Medicina. Universidad del Zulia. Maracaibo. Venezuela
Eliana Ling Toledo
Escuela de Bioanálisis. Facultad de Medicina. Universidad del Zulia. Maracaibo. Venezuela
Daniela Núñez
Maestría de Diagnóstico Bacteriológico. División de Estudios para Graduados. Facultad de Medicina, La Universidad del Zulia. Maracaibo, Venezuela
Messaria Ginestre
Escuela de Bioanálisis. Facultad de Medicina. Universidad del Zulia. Maracaibo. Venezuela
Jessica Villasmil
Escuela de Bioanálisis. Facultad de Medicina. Universidad del Zulia. Maracaibo. Venezuela
José Bermúdez-González
Bios Venezuela C.A.
Rafael Villalobos
Cátedra de Medicina Tropical. Escuela de Medicina. Facultad de Medicina. La Universidad del
Zulia. Maracaibo.Venezuela
Liliana Gómez-Gamboa
Cátedra de Microbiología. Escuela de Medicina. Facultad de Medicina. La Universidad del Zulia.
Maracaibo. Venezuela.
The high incidence of the infectious diseases and the antimicrobial resistance arise represent a public health threat today. The extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are an example of this phenomenon. We determined the ESBL-production in Enterobacteriaceae isolates from a Healthcare Center in Maracaibo, during September 2014 to February 2015. The Kirby-Baüer method was perform to preliminary phenotypic detection of ESBL, according to CLSI guidelines. ESBL-production was confirmed by a double-disk synergy test according to the CLSI standards. To genotypic confirmation, the genes blaCTX-M, blaTEM and blaSHV were amplified by PCR. Fifty-five (n=55) strains were analyzed distributed in Escherichia coli (56.36 %), Klebsiella pneumoniae (21.82 %), Enterobacter cloacae (7.27 %), Proteus mirabilis and Serratia marcescens (5.45 % each one), Salmonella spp. and Morganella morganii (1.82 % each one). The major encoded ESBL was the blaTEM gene (83.63 %); followed by 23.63% of the blaCTX-M gene, and 21.81 % encoded the blaSHV gene. 27.27 % of the isolates produced two or three ESBL simultaneously. These results confirmed the high spread of this resistant mechanism among Enterobacteriaceae-producing infections in our public health institutions, therefore control measures should applied to control and reduce its incidence.